10 Low Risk Penny Stocks to Buy Now

​4. Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)

Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) is one of the Low Risk Penny Stocks to Buy Now. On March 5, UBS analyst David Dai raised the firm’s price target on Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) from $2 to $4, while maintaining a Neutral rating on the stock.

​The improved price target is based on fundamental improvements in fiscal Q4 2025; however, Amtagvi acceleration remains uncertain, said the analyst in his research note. The company reported fiscal Q4 2025 earnings on February 24. Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) grew its quarterly revenue by 17.74% year-over-year to $86.77 million and topped estimates by $5.76 million. The EPS for the quarter came in at negative $0.18 but stayed in line with the consensus.

​Management attributed growth to be driven by the commercialization of AMTAGVI in advanced melanoma. The drug witnessed accelerated uptake across both academic and community treatment centers. Full-year product revenue reached $264 million, driven by a 112% year-over-year increase in AMTAGVI revenue.

​Management noted that the fiscal 2026 revenue guidance will be provided in the near future.

​Iovance Biotherapeutics Inc. (NASDAQ:IOVA) is a commercial-stage biopharmaceutical company that develops and commercializes cell therapies using autologous tumor-infiltrating lymphocytes for the treatment of metastatic melanoma and other solid tumor cancers in the US and internationally.